Merseburger, Axel S. http://orcid.org/0000-0001-6467-3931
Bakshi, Ganesh
Chen, Dong-Yi
Chiong, Edmund
Jabbour, Michel
Joung, Jae Young
Lai, Allen Yu-Hung
Lawrentschuk, Nathan
Le, Tuan-Anh
Ng, Chi Fai
Ng, Choon Ta
Ong, Teng Aik
Pang, Jacob See-Tong
Rabah, Danny M.
Ragavan, Narasimhan
Sase, Kazuhiro
Suzuki, Hiroyoshi
Teo, Michelle Mui Hian
Uemura, Hiroji
Woo, Henry H.
Funding for this research was provided by:
Ferring Pharmaceuticals
Universität zu Lübeck
Article History
Received: 10 October 2023
Accepted: 5 February 2024
First Online: 14 March 2024
Declarations
:
: Axel S. Merseburger––lectures/speaker/honoraria: AstraZeneca, Accord Health, Astellas, Bayer, Bristol-Myers Squibb, Eisai, Ferring, Ipsen, MSD, Merck Serono, Janssen, Takeda, TEVA, Astellas, Novartis, Pfizer, Recordati and Roche; consultant: AstraZeneca, Astellas, Bayer, Bristol-Myers Squibb, Ferring, Ipsen, Janssen, EUSAPharm, MSD, Merck Serono, Novartis, Takeda, Teva, Pfizer, Recordati and Roche; research and clinical trials: AstraZeneca, Astellas, Bayer, Bristol-Myers Squibb, Ipsen, Janssen, EUSAPharm, MSD, Merck Serono, Novartis, Takeda, Teva, Pfizer und Roche. Teng Aik Ong––research grant: Ferring. Ganesh Bakshi––nothing to declare. Dong-Yi Chen––nothing to declare. Edmund Chiong––lectures/speaker/honoraria: Astellas, Janssen, Bayer, AstraZeneca, Ipsen, Amgen, Ferring and Novartis. Michel Jabbour––nothing to declare. Jae Young Joung––nothing to declare. Allen Yu-Hung Lai––an employee of Ferring Pharmaceuticals. Nathan Lawrentschuk––proctor and speaker: Device Technologies and Getz Healthcare; speaker: Astellas; advisory board: Penthrax. Tuan-Anh Le––nothing to declare. Chi Fai Ng––research grant: Astellas, Takeda, Bayer and Ipsen; investigator in studies: Bayer, Astellas and Pfizer; speaker: Janssen. Choon Ta Ng––lectures/speaker/honoraria: AstraZeneca, Ferring and Novartis. Jacob See-Tong Pang––nothing to declare. Danny M. Rabah––nothing to declare. Narasimhan Ragavan––nothing to declare. Kazuhiro Sase––nothing to declare. Hiroyoshi Suzuki––research grants: Astellas, Bayer, Janssen and Nihon Kayaku; consulting fees and honoraria: Astellas, AstraZeneca, Bayer, Chugai, Daiichi-Sankyo, Eli-Lily, Janssen, MSD, Roche and Sanofi. Michelle Mui Hian Teo––an employee of Ferring Pharmaceuticals. Hiroji Uemura––advisory board: Ferring, Bayer, AstraZeneca, Janssen, Astellas, Takeda and Ono Pharm.; speaker: Sanofi, Pfizer, MSD, Chugai, Nihon Kayaku, Nippon Shinyaku, Kissei and Kyowa-Kirin. Henry H. Woo––study sponsor: Prodeon; consulting fees: Astellas, Janssen, Mundipharma, Ferring, Medical Developments International and Boston Scientific; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Ferring and Bayer; leadership or fiduciary role in other board, society, committee or advocacy group: Royal Australasian College of Surgeons, Urological Society of Australia and New Zealand, Australasian Urological Foundation and Australian and New Zealand Urogenital and Prostate Trials Group; receipt of equipment, materials, drugs, medical writing, gifts or other services: Prospection Pty Ltd., and Prodeon.
: Not applicable.
: Not applicable.